NF-KAPPAB1 DEFICIENCY WORSENS NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN MICE BY PROMOTING LYMPHOCYTE-MEDIATED RESPONSES

被引：0
|
作者：
Locatelli, I. [1 ]
Sutti, S. [1 ]
Vacchiano, M. [1 ]
Bozzola, C. [1 ]
Albano, E. [1 ]
机构：
[1] Univ E Piedmont, Dept Med Sci, Novara, Italy
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
10.1016/S0168-8278(12)61259-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1247
引用
收藏
页码：S493 / S494
页数：2
相关论文
共 50 条
  • [11] Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis
    Coombes, Jason D.
    Choi, Steve S.
    Swiderska-Syn, Marzena
    Manka, Paul
    Reid, Danielle T.
    Palma, Elena
    Briones-Orta, Marco A.
    Xie, Guanhua
    Younis, Rasha
    Kitamura, Naoto
    della Peruta, Marco
    Bitencourt, Shanna
    Dolle, Laurent
    Oo, Ye Htun
    Mi, Zhiyong
    Kuo, Paul C.
    Williams, Roger
    Chokshi, Shilpa
    Canbay, Ali
    Claridge, Lee C.
    Eksteen, Bertus
    Diehl, Anna Mae
    Syn, Wing-Kin
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2016, 1862 (01): : 135 - 144
  • [12] PRESENCE OF LIVER ANGIOGENESIS AND UPREGULATION OF VEGF IN A MICE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Coulon, Stephanie H.
    Geerts, Anja M.
    Casteleyn, Christophe
    Heindryckx, Femke
    Van Steenkiste, Christophe
    Libbrecht, Louis
    Van Vlierberghe, Hans
    Colle, Isabelle
    HEPATOLOGY, 2010, 52 (04) : 1062A - 1063A
  • [13] A further improved animal model for non-alcoholic steatohepatitis (NASH) in mice (the third repot)
    Ushijima, Souta
    Oshikata, Takafumi
    Yokota, Mariko
    Yamamoto, Miyuki
    Saruwatari, Mika
    Beppu, Namie
    Morizumi, Kousuke
    Katayama, Seiichi
    Atai, Hiroshi
    Nishi, Katsuhide
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 225P - 225P
  • [14] Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH)
    Jin, Cheng Jun
    Sellmann, Cathrin
    Engstler, Anna Janina
    Ziegenhardt, Doreen
    Bergheim, Ina
    BRITISH JOURNAL OF NUTRITION, 2015, 114 (11) : 1745 - 1755
  • [15] Notch-mediated epithelial/mesenchymal interaction influences non-alcoholic steatohepatitis (NASH) progression
    Morell, Carola M.
    Fiorotto, Romina
    Meroni, Marica
    Raizner, Aileen
    Cadamuro, Massimiliano
    Albano, Emanuele
    Strazzabosco, Mario
    HEPATOLOGY, 2014, 60 : 730A - 730A
  • [16] Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
    Oldham, Stephanie
    Rivera, Christian
    Boland, Michelle L.
    Trevaskis, James L.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (146):
  • [17] Morroniside delays the progression of non-alcoholic steatohepatitis by promoting AMPK-mediated lipophagy
    Zhang, Cong
    Tong, Qiao
    Liu, Kexin
    Mao, Tongyun
    Song, Yingying
    Qu, Yaqin
    Chen, Xin
    Qiu, Zhenpeng
    PHYTOMEDICINE, 2024, 129
  • [18] Case of GPD1 deficiency causing hypertriglyceridaemia and non-alcoholic steatohepatitis
    Polchar, Leo
    Vallabhaneni, Pramodh
    BMJ CASE REPORTS, 2022, 15 (04)
  • [19] Treatment of experimental non-alcoholic steatohepatitis by targeting α7 nicotinic acetylcholine receptor-mediated inflammatory responses in mice
    Zhou, Zhou
    Liu, Ying-Chao
    Chen, Xiao-Mei
    Li, Fu-Qiang
    Tong, Xiao-Juan
    Ding, Yue-Ping
    Tang, Cui-Lan
    MOLECULAR MEDICINE REPORTS, 2015, 12 (05) : 6925 - 6931
  • [20] Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Bifari, Francesco
    Manfrini, Roberto
    Cas, Michele Dei
    Berra, Cesare
    Siano, Matteo
    Zuin, Massimo
    Paroni, Rita
    Folli, Franco
    PHARMACOLOGICAL RESEARCH, 2018, 137 : 219 - 229
12345